• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血友病A患者注射纤维蛋白原降解产物和因子VIII的体内分析结果]

[Results of in vivo analysis of injected fibrinogen degradation products and factor VIII in patients with hemophilia A].

作者信息

Kätzel R, Kubel M, Scheel H, Wegner H

出版信息

Z Gesamte Inn Med. 1978 Aug 1;33(15):525-9.

PMID:695793
Abstract

Seven patients with haemophilia A CP were injected in a dosage of 1 to 3 double units, which were stored for 127 days partly deep-frozen, partly lyophilized and after this time contained fibrinogen fission products (16--256 microgram/ml). Though in two patients after the transfusion positive WA of the injected fibrinogen fission products were established, a relevant influence on the fibrinogen fission product levels of the patients is to be expected only after administration of larger quantities of such preparations. The therapeutic efficacy of the stored CP was insufficient, since despite good in-vitro-activities of factor VIII the increase of factor VIII in four patients was slight and retarding and did not take place in three patients.

摘要

7例甲型血友病慢性期患者接受了1至3个双单位的注射,这些制剂部分深冻、部分冻干保存了127天,此时含有纤维蛋白原裂解产物(16 - 256微克/毫升)。尽管两名患者输血后检测到所注射纤维蛋白原裂解产物的华氏反应呈阳性,但预计只有在给予大量此类制剂后才会对患者的纤维蛋白原裂解产物水平产生显著影响。储存的冷沉淀治疗效果不佳,因为尽管因子VIII的体外活性良好,但4例患者的因子VIII增加轻微且延迟,3例患者未出现增加。

相似文献

1
[Results of in vivo analysis of injected fibrinogen degradation products and factor VIII in patients with hemophilia A].[血友病A患者注射纤维蛋白原降解产物和因子VIII的体内分析结果]
Z Gesamte Inn Med. 1978 Aug 1;33(15):525-9.
2
[Occurrence and behavior of fibrin fibrinogen degradation products in concentrates of factor VIII, cryoprecipitate and dextran precipitate during long-term preservation].[长期保存期间VIII因子浓缩物、冷沉淀和右旋糖酐沉淀中纤维蛋白原降解产物的出现及行为]
Z Gesamte Inn Med. 1977 Nov 15;32(22):603-11.
3
[Effect of plasma and/or factor VIII concentrates administration on platelet functions in patients with haemophilia A and von Willebrand's disease (author's transl)].血浆和/或凝血因子VIII浓缩物给药对甲型血友病和血管性血友病患者血小板功能的影响(作者译)
Haematologica. 1975 Jun;60(2):168-83.
4
Factor VIII concentrate for hemophilia: comparison of two heat-treated products.用于血友病的凝血因子 VIII 浓缩剂:两种热处理产品的比较。
CMAJ. 1987 Jan 15;136(2):150-2.
5
In vivo recovery of factor VIII following transfusion: a survey of recent data and publications to assess the influence of standards used for potency assignment. On behalf of the Subcommittee on Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
Thromb Haemost. 1995 Oct;74(4):1191-6.
6
[Inhibitor hemophilia A--diagnostic and therapeutic significance of controlled substitutions with factor VIII].[抑制性血友病A——凝血因子VIII控制替代治疗的诊断和治疗意义]
Beitr Infusionsther. 1990;26:174-8.
7
Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate.接受冻干因子VIII浓缩物和冷沉淀的经典血友病患者的免疫功能障碍。
Can Med Assoc J. 1983 Oct 1;129(7):713-7.
8
A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.一种在血液中心使用一次性袋系统对冷沉淀进行溶剂-去污剂处理的微池工艺。
Vox Sang. 2006 Jul;91(1):56-62. doi: 10.1111/j.1423-0410.2006.00772.x.
9
In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion.通过持续输注递送超纯凝血因子VIII浓缩物期间的体外凝血因子VIII回收率。
Am J Hematol. 1996 Feb;51(2):99-103. doi: 10.1002/(SICI)1096-8652(199602)51:2<99::AID-AJH1>3.0.CO;2-1.
10
[Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
Z Gesamte Inn Med. 1982 Oct 1;37(19):641-4.